Form 4: Baxter International EVP and CFO Joel T. Grade Reports Acquisition of Common Stock
SEC Form 4 Filing
Joel T. Grade, EVP and CFO of Baxter International, reports the acquisition of 42,867 shares of common stock and holdings of 96,623 shares.
Summary
- On March 6, 2024, Joel T. Grade, the EVP and CFO of Baxter International Inc., acquired 42,867 shares of Baxter's common stock.
- This acquisition was part of his annual equity grant, consisting of 50% restricted stock units (RSUs) and 50% performance share units (PSUs).
- The reported transaction also includes the automatic reinvestment of dividends and shares held in Baxter's Employee Stock Plan.
- Following the reported transaction, Grade beneficially owns 96,623 shares of Baxter's common stock.
- A Power of Attorney was executed on March 7, 2024, granting David S. Rosenbloom, Ellen K. Bradford, and Kimberly Olson the authority to act on Grade's behalf for SEC filings related to Baxter securities.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by the CFO suggests confidence in the company, but it's a routine transaction.
Positives
- The acquisition of shares by a high-ranking executive could be interpreted positively by investors, signaling confidence in the company's future.
Future Outlook
The PSU grants are subject to potential disclosure at a later date upon the satisfaction of the related performance and time vesting conditions.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The acquisition of shares by the CFO is a common occurrence and is generally viewed as a positive sign.
Comparison to Industry Standards
- Executive stock ownership is a common practice across publicly traded companies.
- Companies like Medtronic, Johnson & Johnson, and Abbott also have similar equity grant programs for their executives.
- The vesting schedules and types of equity grants (RSUs and PSUs) are fairly standard within the healthcare industry.
Stakeholder Impact
- The acquisition of shares by a high-ranking executive could be interpreted positively by shareholders.
Next Steps
- The PSU grants are subject to potential disclosure at a later date upon the satisfaction of the related performance and time vesting conditions.
- RSUs are scheduled to vest in three equal annual installments beginning on March 6, 2025.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of transaction: Acquisition of common stock and grant of RSUs. |
| 03/06/2025 | First anniversary of the grant date; first vesting date for RSUs. |
| 03/07/2024 | Date of execution of Power of Attorney. |
| 03/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.